AI in optimized cancer treatment: laying the groundwork for interdisciplinary progress.

Journal: Oxford open immunology
Published Date: Jan 1, 2025

Abstract

The molecular complexity of cancer presents significant challenges to traditional therapeutic approaches, necessitating the development of innovative treatment strategies capable of addressing the disease's dynamic nature and resistance mechanisms. Data-driven methodologies, particularly those employing Artificial Intelligence (AI), hold substantial promise by advancing a comprehensive understanding of the intricate molecular and cellular mechanisms underlying cancer and supporting the development of adaptive, patient-specific therapeutic strategies. Initiated through the Mertelsmann Foundation, the Collaborative Research Institute Intelligent Oncology (CRIION) in Freiburg im Breisgau, Germany, aims to drive progress in AI-driven oncology. CRIION fosters global collaboration through initiatives like the Intelligent Oncology Symposium and supports multidisciplinary projects designed to integrate AI innovations into clinical workflows.

Authors

  • Gabriel Kalweit
    Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany.
  • Evelyn Ullrich
    Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Baden-Württemberg, 79110, Germany.
  • Joschka Boedecker
  • Roland Mertelsmann
    Dept. Medicine 1, Freiburg University Medical Center, Freiburg, Germany.
  • Maria Kalweit
    Department of Computer Science, University of Freiburg, Freiburg, Germany.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals